Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 8-K Event Shareholder vote results
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. DEF 14A Proxy Proxy Statement
  9. 8-K Event Other events
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. 4 Open-market sale 10% owner sold 21,132 shares at an average $13.91 ($293,843)
  13. 4 Open-market sale Director sold 21,132 shares at an average $13.91 ($293,843)
  14. 4 Other acquisition 10% owner acquired 79,245 shares (other)
  15. 4 Other disposition 10% owner disposed of 700,000 shares (other)
  16. SC 13G Stake Amended Statement of Ownership
  17. 8-K Event Other events
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. CT ORDER Other Confidential Order

Page 32 of 37 · 725 filings